DOCSLIB.ORG

Guidance for Industry Q10 Pharmaceutical Quality System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Guidance for Industry Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) April 2009 ICH Guidance for Industry Q10 Pharmaceutical Quality System Additional copies are available from: Office of Communication Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave.,Bldg. 51, Room 2201 Silver Spring, MD 20993-0002 (Tel) 301-796-3400 http://www.fda.gov/cder/guidance/index.htm Office of Communication, Outreach and Development, HFM-40 Center for Biologics Evaluation and Research Food and Drug Administration 1401 Rockville Pike, Rockville, MD 20852-1448 (Tel) 1-800-835-4709 or 301-827-1800 http://www.fda.gov/cber/guidelines.htm. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) April 2009 ICH TABLE OF CONTENTS I. INTRODUCTION (1, 1.1)................................................................................................ 1 II. PHARMACEUTICAL QUALITY MANAGEMENT SYSTEM ................................. 2 A. Scope (1.2).......................................................................................................................................2 B. Relationship of ICH Q10 to Regional GMP Requirements, ISO Standards, and ICH Q7 (1.3)............................................................................................................................3 C. Relationship of ICH Q10 to Regulatory Approaches (1.4).........................................................3 D. ICH Q10 Objectives (1.5) ..............................................................................................................3 E. Enablers: Knowledge Management and Quality Risk Management (1.6) ............................... 4 F. Design and Content Considerations (1.7) ....................................................................................4 G. Quality Manual (1.8)......................................................................................................................5 III. MANAGEMENT RESPONSIBILITY (2)...................................................................... 5 A. Management Commitment (2.1)...................................................................................................5 B. Quality Policy (2.2).........................................................................................................................6 C. Quality Planning (2.3)....................................................................................................................6 D. Resource Management (2.4)..........................................................................................................7 E. Internal Communication (2.5) ......................................................................................................7 F. Management Review (2.6)............................................................................................................7 G. Management of Outsourced Activities and Purchased Materials (2.7)....................................7 H. Management of Change in Product Ownership (2.8) .................................................................8 IV. CONTINUAL IMPROVEMENT OF PROCESS PERFORMANCE AND PRODUCT QUALITY (3) ............................................................................................... 8 A. Lifecycle Stage Goals (3.1) ............................................................................................................8 B. Pharmaceutical Quality System Elements (3.2) ..........................................................................9 V. CONTINUAL IMPROVEMENT OF THE PHARMACEUTICAL QUALITY SYSTEM (4) .................................................................................................................... 13 A. Management Review of the Pharmaceutical Quality System (4.1)..........................................13 B. Monitoring of Internal and External Factors That Can Have an Impacton the Pharmaceutical Quality System (4.2).........................................................................................13 C. Outcomes of Management Review and Monitoring (4.3).........................................................14 VI. GLOSSARY (5)............................................................................................................... 15 Annex I: Potential Opportunities To Enhance Science- and Risk-Based Regulatory Approaches *............................................................................................................... 18 Annex 2: Diagram of the ICH Q10 Pharmaceutical Quality System Model…..……………19 i Guidance for Industry1 Q10 Pharmaceutical Quality System This guidance represents the Food and Drug Administration's (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance. I. INTRODUCTION (1, 1.1)2 This internationally harmonized guidance is intended to assist pharmaceutical manufacturers by describing a model for an effective quality management system for the pharmaceutical industry, referred to as the pharmaceutical quality system. Throughout this guidance, the term pharmaceutical quality system refers to the ICH Q10 model. ICH Q10 describes one comprehensive model for an effective pharmaceutical quality system that is based on International Organization for Standardization (ISO) quality concepts, includes applicable good manufacturing practice (GMP) regulations, and complements ICH “Q8 Pharmaceutical Development” and ICH “Q9 Quality Risk Management.”3 ICH Q10 is a model for a pharmaceutical quality system that can be implemented throughout the different stages of a product lifecycle. Much of the content of ICH Q10 applicable to manufacturing sites is currently specified by regional GMP requirements. ICH Q10 is not intended to create any new expectations beyond current regulatory requirements. Consequently, the content of ICH Q10 that is additional to current regional GMP requirements is optional. 1 This guidance was developed within the Expert Working Group (Quality) of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) and has been subject to consultation by the regulatory parties, in accordance with the ICH process. This document has been endorsed by the ICH Steering Committee at Step 4 of the ICH process, June 2008. At Step 4 of the process, the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan, and the United States. 2 Arabic numbers reflect the organizational breakdown of the document endorsed by the ICH Steering Committee at Step 4 of the ICH process, June 2008. 3 These guidances are available on the Internet at http://www.fda.gov/cder/guidance/index.htm. We update guidances periodically. To make sure you have the most recent version of a guidance, check the CDER guidance page at http://www.fda.gov/cder/guidance/index.htm 1 ICH Q10 demonstrates industry and regulatory authorities’ support of an effective pharmaceutical quality system to enhance the quality and availability of medicines around the world in the interest of public health. Implementation of ICH Q10 throughout the product lifecycle should facilitate innovation and continual improvement and strengthen the link between pharmaceutical development and manufacturing activities. FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required. II. PHARMACEUTICAL QUALITY MANAGEMENT SYSTEM A. Scope (1.2) This guidance applies to the systems supporting the development and manufacture of pharmaceutical drug substances (i.e., active pharmaceutical ingredients (APIs)) and drug products, including biotechnology and biological products, throughout the product lifecycle. The elements of ICH Q10 should be applied in a manner that is appropriate and proportionate to each of the product lifecycle stages, recognizing the differences among, and the different goals of, each stage (see section IV (3)). For the purposes of this guidance, the product lifecycle includes the following technical activities for new and existing products: • Pharmaceutical Development o Drug substance development o Formulation development (including container/closure system) o Manufacture of investigational products o Delivery system development (where relevant) o Manufacturing process development and scale-up o Analytical method development • Technology Transfer o New product transfers during development through manufacturing o Transfers within or between manufacturing and testing sites for marketed products • Commercial
Load more

Recommended publications
  • Corporate Culture and Organizational Change- a Study on a Large Pharmaceutical Company in Bangladesh
    Asian Business Review, Volume 4, Number 2/2014 (Issue 8) ISSN 2304-2613 (Print); ISSN 2305-8730 (Online) 0 Corporate Culture and Organizational Change- a Study on a Large Pharmaceutical Company in Bangladesh S.M. Rezaul Ahsan Senior Manager, Organization Development, The ACME Laboratories Ltd, Dhaka, BANGLADESH ABSTRACT This paper investigates the relationship between corporate culture and attitudes toward organizational change from the perspectives of a large pharmaceutical company in Bangladesh. A structured questionnaire was developed on the basis of the competing values framework of culture typology of Cameron and Quinn (2006) and a study of Justina Simon (June 2012), which was distributed to the 55 staff members of the company. The result shows that there is a significant relationship between corporate culture and organizational change. The study reveals that the organization has adopted all four types of organizational culture and the dominant existing organizational culture is the hierarchy culture. The study also shows that the resistance to change is a function of organizational culture. The implications of the study are also discussed. Key Words: Organizational Culture, Organizational Change, Resistance to change, Change Management JEL Classification Code: G39 INTRODUCTION Corporate culture is a popular and versatile concept in investigate the impact of organizational culture on C the field of organizational behavior and has been organizational change. identified as an influential factor affecting the success There has been significant research in the literature to and failure of organizational change efforts. Culture can explore the impact of organizational culture on both help and hinder the change process; be both a blessing organizational change.
    [Show full text]
  • Quality Enhancement of Corporate Management Systems: an Overview of Best Management Practices
    Journal of Service Science and Management, 2014, 7, 302-312 Published Online August 2014 in SciRes. http://www.scirp.org/journal/jssm http://dx.doi.org/10.4236/jssm.2014.74027 Quality Enhancement of Corporate Management Systems: An Overview of Best Management Practices Giron Kamonja1*, Yan Liang1, Muhammad Tayyab Sohail2, Shahzad Ahmad Khan1 1School of Economic and Management, China University of Geosciences (Wuhan), Wuhan, China 2School of Public Administration, China University of Geosciences (Wuhan), Wuhan, China Email: *[email protected], [email protected] Received 25 April 2014; revised 21 May 2014; accepted 15 June 2014 Copyright © 2014 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract In this my present study, I elaborate different types of management, management staffs, types of managers and leaders along with their capacities of work and their roles in any organization or institute to achieve the desired goal with the help of employees. A study found that most of the CEOs of the 62 major US-based companies spent at least 10 percent of their time in quality en- hancement efforts. The critical importance of employees’ involvement in the quality process of an organization is based on the belief that the best process innovation ideas come from the people actually doing the job. Employee involvement in quality efforts can only come about when the em- ployees know that the organization cares for them. Best companies do not just confine education and training to their shop floor employees and managers.
    [Show full text]
  • Organizational Culture and Knowledge Management Success at Project and Organizational Levels in Contracting Firms
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PolyU Institutional Repository This is the Pre-Published Version. Organizational Culture and Knowledge Management Success at Project and Organizational Levels in Contracting Firms Patrick S.W. Fong1 and Cecilia W.C. Kwok2 ABSTRACT This research focuses on contracting firms within the construction sector. It characterizes and evaluates the composition of organizational culture using four culture types (Clan, Adhocracy, Market, and Hierarchy), the strategic approach for knowledge flow, and the success of KM systems at different hierarchical levels of contracting organizations (project and parent organization level). Responses from managers of local or overseas contracting firms operating in Hong Kong were collected using a carefully constructed questionnaire survey that was distributed through electronic mail. The organizational value is analyzed in terms of the four cultural models. Clan culture is found to be the most popular at both project and organization levels, which means that the culture of contracting firms very much depends on honest communication, respect for people, trust, and cohesive relationships. On the other hand, Hierarchy 1 Associate Professor, Department of Building & Real Estate, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong (corresponding author). T: +(852) 2766 5801 F: +(852) 2764 5131 E-mail: [email protected] 2 Department of Building & Real Estate, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong. 1 culture, which focuses on stability and continuity, and analysis and control, seems to be the least favored at both levels. Another significant finding was that the two main KM strategies for knowledge flow, Codification and Personalization, were employed at both project and organization levels in equal proportion.
    [Show full text]
  • Mediating Customer Relationship Management on the Effect of Incremental Innovation on Product Life Cycle
    INTERNATIONAL JOURNAL OF SCIENTIFIC & TECHNOLOGY RESEARCH VOLUME 8, ISSUE 09, SEPTEMBER 2019 ISSN 2277-8616 Mediating Customer Relationship Management On The Effect Of Incremental Innovation On Product Life Cycle Erna Setijani, Sumartono, Pudjo Sugito Abstract: This study aims to analyze the mediating customer relationship management on the effect of incremental innovation on product life cycle. The population of this study are batik entrepreneurs in Madura island, Indonesia. The sampling technique uses a proportional random sampling at three locations, namely: Bangkalan, Sampang, Pamekasan and Sumenep Regency. The number of respondents is 200 batik entrepreneurs. This research was carried out by designing questionnaire and testing the validity dan reliability of research instrument. Furthermore, the questionnaire was broadcasted to the batik entrepreneurs who were randomly selected. The primary data was analyzed using structural equation model with the Partial Least Square (PLS) data processing program. The result of this study demonstrates that incremental innovation affects customer relationship management, incremental innovation affects product life cycle, customer relationship management affects product lifecycle and incremental innovation affect indirectly product life cycle through customer relationship management. It means that both incremental innovation and customer management relationship can extend product life cycle of Madures Batik. Index Terms: Incremental Innovation, Customer Relationship Management, Product Life Cycle ———————————————————— 1 NTRODUCTION Industry, Indonesia, 2018). Unfortunately, the marketing of Batik is attached as a cultural part of several regions such Madurese batik products remains ups and downs. In fact, in as Solo, Yogyakarta, and Pekalongan. In East Java, the past three (3) years, it has stagnated and dropped. The Madura Island, besides being known as a salt island, has results of preliminary studies indicate that Bangkalan turned out to have a wealth of cultural sites, i.e.
    [Show full text]
  • The Product Life Cycle : It's Role in Marketing Strategy/Some Evolving
    UNIVERSITY OF ILLINOIS LIBRARY AT URBANACHAMPAIGN BOOKSTACKS £'*- ^3 Digitized by the Internet Archive in 2011 with funding from University of Illinois Urbana-Champaign http://www.archive.org/details/productlifecycle1304gard BEBR FACULTY WORKING PAPER NO. 1304 The Product Life Cycle: It's Role in Marketing Strategy/Some Evolving Observations About the Life Cycle David M. Gardner College of Commerce and Business Administration Bureau of Economic and Business Research University of Illinois, Urbana-Champaign BEBR FACULTY WORKING PAPER NO. 1304 College of Commerce and Business Administration University of Illinois Urbana-Champaign November 1986 The Product Life Cycle: It's Role in Marketing Strategy/ Some Evolving Observations About the Life Cycle David M. Gardner, Professer Department of Business Administration The Product Life Cycle: It's Role In Marketing Strategy- Some Evolving Observations About The Product Life Cycle The Product Life Cycle is an attractive concept, but one which the common consensus is that it has some descriptive value, but rather limited or non-existent prescriptive value. This paper is based on the premise the Product Life Concept has the potential to become a central, if not, the central concept in marketing theory and practice. Prior to making suggestions on steps toward this ambitious goal, the concept is reviewed along with its major limitations. Based on a review of research evidence published since 1975, it is suggested that three areas need to be explored and expanded. The first is a careful reexamination of the foundation of the concept, then there needs to be a focus on the product life cycle as a dependent variable, and third, there is a need from application of meta-theory criteria to guide future research.
    [Show full text]
  • Product Quality Management
    P8: Pharmaceutical Quality System Elements: Process Performance and Product Quality Monitoring System By Deborah Baly, PhD Product Quality Management Deborah Baly, Ph.D Sr. Director, Commercial Product Quality Management, GNE/ROCHE 1 Presentation Outline: • Product Quality Management – Regulatory landscape and need for integrated product quality management • Role of the Product Quality Steward – Product quality oversight by linking systems, data, and people • Product Lifecycle Management - Commercial Product Lifecycle approach • Conclusions P8: Pharmaceutical Quality System Elements: Process Performance and Product Quality Monitoring System By Deborah Baly, PhD Regulatory Landscape Growing Expectations for Modern Manufacturing • Quality is built in • Lifecycle approach from Development to Product Discontinuation • Understand complex supply chain CMO networks • Robust process measurement & analytical tools •Real‐time assessment of product & process capability • Maintaining “state of control” throughout commercial lifecycle Product Quality Management: Fundamental Elements Product Complaints • Identifying early warning signals of product quality issues in the field Product Assessment & Trending • Proactive assessment of product quality attributes across the manufacturing process Product Quality Stewards • Single point of Contact for Quality to key stakeholders • Routine assessment of product control plans to address trends • 8 Qtr Plan provides foresight and proactive approach QC testing network support • Harmonized approach to test method
    [Show full text]
  • Mckinsey Quarterly 2015 Number 4.Pdf
    2015 Number 4 Copyright © 2015 McKinsey & Company. All rights reserved. Published since 1964 by McKinsey & Company, 55 East 52nd Street, New York, New York 10022. Cover illustration by Vasava McKinsey Quarterly meets the Forest Stewardship Council (FSC) chain-of- custody standards. The paper used in the Quarterly is certified as being produced in an environ- mentally responsible, socially beneficial, and economi- cally viable way. Printed in the United States of America. 2015 Number 4 This Quarter It’s almost a truism these days to say that modern corporations must be agile. The pace of industry disruption arising from the digital revolution, combined with nimble, new competitors—including many from emerging markets—have raised the cost of complacency and rigidity. But what does it mean to achieve agility? This issue’s cover package tries to answer that question, starting with intriguing new McKinsey research. Using data from McKinsey’s Organizational Health Index, Michael Bazigos, Aaron De Smet, and Chris Gagnon show how organizations that combine speed with stability are far likelier to be healthy than companies that simply move fast. The utility sector is a striking example of one industry that needs to combine flexibility and stability. Although digital competitors, new data-based business models, and renewable-energy sources are changing the landscape in certain markets, the industry’s sprawl- ing base of heavy assets remains core to its future. Sven Heiligtag and his colleagues Dominik Luczak and Eckart Windhagen describe how a number of leading utilities are trying to straddle these two worlds, suggesting some lessons for companies in other sectors.
    [Show full text]
  • The Collaborative Organization: How to Make Employee Networks Really Work
    FALL 2010 VOL.52 NO.1 The Collaborative Organization: How to Make Employee Networks Really Work By Rob Cross, Peter Gray, Shirley Cunningham, Mark Showers and Robert J. Thomas BROUGHT TO YOU BY REPRINT NUMBER 52121 MANAGING COLLABORATION The Collaborative Organization: How to Make Employee Networks Really Work THE LEADING The traditional methods for driving operational excellence in QUESTION How can global organizations are not enough. The most effective companies organizations make smart use of employee networks to reduce build more costs, improve efficiency and spur innovation. collaborative BY ROB CROSS, PETER GRAY, SHIRLEY CUNNINGHAM, MARK SHOWERS AND ROBERT J. THOMAS and innovative organizations? FINDINGS Executives should AS INFORMATION TECHNOLOGY becomes increasingly critical within large, global or- analyze employee collaboration net- ganizations, chief information officers are being held to ever-higher performance standards. A recent works to discover survey of 1,400 CIOs illustrates this mandate, with streamlining business processes, reducing enter- how high-perform- ing individuals and prise costs and improving work force effectiveness at the top of their agendas.1 But beyond providing teams connect. efficient operational support, top management increasingly expects the IT department to be a strate- Networks should be designed to gic business partner — to forecast the business impact of emerging technologies, lead the development optimize the flow of new IT-enabled products and services, and drive adoption of innovative technologies that differ- of good ideas across function, distance entiate the organization from competitors. and technical specialty. CIOs often try to address these challenges by relying on the same managerial tools they use to pur- Network analysis sue operational excellence: establishing well-defined roles, best practice processes and formal can show where too much connec- accountability structures.
    [Show full text]
  • Module 4 Responsibilities of Senior Management
    Module 4 Responsibilities of senior management Presented by Neil Redman IAEA International Atomic Energy Agency Key to the organization's success It is fundamental to the success of the Management System and to the implementation of continual improvement throughout the organization that senior managers provide strong leadership; visible and active support; and, demonstrated commitment. IAEA 2 Manager or Leader? Management = a function • Planning • Budgeting • Evaluating • Facilitating Leadership = a relationship • Selecting talent • Motivating • Coaching • Building Trust IAEA 3 Comparison of managers and leaders Managers tend to … Leaders tend to … • …stress organization, • … stress relationships with coordination, and control of others, values and resources (e.g., plant, commitment – the emotional equipment, and people). and spiritual aspects of the organization . • … • … focus on the create and articulate a achievement of short-term vision of what the objectives and goals. organization could achieve in the long run. IAEA 4 Comparison of managers and leaders Managers tend to … Leaders tend to … • … concentrate on • … move the organization in maximizing results from new directions – being existing functions and unsatisfied with maintaining systems. the status quo. • … insist that people check • … empower people to act on with them on every detail their own to achieve before they act. objectives. IAEA 5 Comparison of managers and leaders Managers tend to … Leaders tend to … • … enforce fulfillment of • … generate a feeling of agreements and contracts meaning in work – its value for work. and importance. • … tend not to push • … have an insatiable themselves to learn new passion to continuously things. develop themselves – eager to learn. IAEA 6 Managers and Leaders • Managers may be Leaders but Leaders are not necessarily Managers • Managers ‘provide’ and ‘control’ • Leaders take us to a better place IAEA 7 Management cycle Establish the organisation’s vision, goals, objectives & behaviours Ensure the Review and improve the management team are vision etc.
    [Show full text]
  • Future Directions for Product Lifecycle Management (Plm) and Model-Based Systems Engineering (Mbse)
    FUTURE DIRECTIONS FOR PRODUCT LIFECYCLE MANAGEMENT (PLM) AND MODEL-BASED SYSTEMS ENGINEERING (MBSE) Sanford Friedenthal, SAF Consulting Sponsored by Aras Future Directions for Product Lifecycle Management (PLM) and Model-based Systems Engineering (MBSE) Future Directions for Product Lifecycle Management (PLM) and Model-based Systems Engineering (MBSE) SANFORD FRIEDENTHAL, SAF CONSULTING 1. INTRODUCTION Industries such as automotive, aerospace, biomedical, and telecommunications, continue to face increasing system and product development challenges that require a strategic response. Organizations must innovate to advance technology at an accelerating rate in areas such as computing, networking, sensors, and materials, and insert these technologies into their product development. They must manage growing system complexity that results from increased system and software functionality and inter-connectedness. The need for new technologies and increases in system complexity are often in response to customer demands for smarter and more autonomous systems that require less human interaction and are more fault tolerant and secure. Organizations must provide this capability within the constraints of shortened development cycles and reduced costs, while relying on extended supply chains, all to meet increasing global competition. An organization’s capability to develop and evolve systems must address these challenges to stay competitive. The development process is complex in its own right and involves interaction and collaboration among many different engineering disciplines and other stakeholders across the lifecycle. The development process must also facilitate innovation, while at the same time, leverage previous design experience and knowledge that builds on existing products. Today’s multi-disciplinary engineering practices are often stove-piped and disconnected creating many inefficiencies, rework, and limit the opportunity for reuse.
    [Show full text]
  • Corporate Governance Guidelines
    CORPORATE GOVERNANCE GUIDELINES A. Role of the Board of Directors The Board of Directors (“Board”) is elected by shareholders to provide oversight to senior management in their management of Covance Inc. (“Covance”). Consistent with its fiduciary duty, the Board exercises its oversight to enhance the long term value of Covance to its shareholders. The Board recognizes that long-term value is enhanced in part by responsibly taking account of other stakeholders and interested partners, such as customers, employees, suppliers, and the public. The Board has adopted these guidelines to set forth the principles of corporate governance under which the Board expects to operate. The Board will review these guidelines from time to time and make such changes as it deems necessary and appropriate. B. Board Responsibilities 1. General Oversight The Board’s oversight of senior management in their management of Covance will include review and discussion of the performance of Covance and its management, its strategies, plans and prospects, and other matters of significant importance. 2. Ethical and Lawful Conduct Each director shall adhere to the applicable Covance policies concerning integrity and ethical behavior which the Company’s management and employees are subject, including without limitation the Covance Code of Conduct and its policies on securities law compliance. Covance’s Code of Conduct is posted at Covance’s website (Covance.com). In exercising their oversight of Covance, the directors expect the company’s senior management and its outside advisors and auditors to act with honesty and integrity and the Board expects reasonably to rely on their honesty and integrity. If an actual or potential conflict of interest arises for a director, the director shall promptly inform the CEO and the presiding director for the pending meeting.
    [Show full text]
  • Overview to Teamcenter Product Lifecycle Sourcing Closing the Loop Between Your Product Procurement and Product Development Processes
    Teamcenter Overview to Teamcenter Product Lifecycle Sourcing Closing the loop between your product procurement and product development processes fact sheet Siemens PLM Software www.siemens.com/plm Summary Siemens PLM Software teams with A.T. Kearney Procurement Solutions to facilitate Teamcenter ® Product Lifecycle Sourcing software – a compre hensive range of software and services that product makers can use to digitally transform product procurement and sourcing and integrate these processes with the rest of the engineering and product development initiatives driven by product lifecycle management (PLM). Defining Teamcenter The challenge Product Lifecycle Sourcing In today’s economy, even a modest Provides procurement and improvement in the cost of doing engineering teams with real-time business can yield a tremendous access to a single source of product and process data competitive edge. Leading companies Streamlines information flow recognize this and their executives between your procurement and are giving unprecedented attention to engineering teams and facilitates the procurement process as a means “closed loop” communications between purchasing and product for improving shareholder value. development by leveraging Chief procurement officers are under intellectual capital created by these pressure to minimize purchasing disciplines in otherwise isolated information silos costs and enhance the value of their Enables product makers to company’s supplier relationships. eliminate duplicate parts/designs For example, consider the views
    [Show full text]